NCT00904943View on ClinicalTrials.gov

Topiramate 25 mg Capsules Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Healthy
Interventions
DRUG

Topiramate Capsules, 25 mg

2 x 25 mg Capsules

DRUG

Topamax® Capsules, 25 mg

2 x 25 mg Capsules

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00904943 - Topiramate 25 mg Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter